KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

Lucknow: King George’s Medical University (KGMU) will file an FIR against four employees after a probe found alleged irregularities worth around Rs 2.5 crore in medicines procurement under the Asadhya Yojana. The scheme provides free treatment to poor patients with chronic diseases.

A five-member inquiry committee found irregularities in the urology department and recommended action against one regular pharmacist and three contractual employees.

KGMU spokesperson Prof KK Singh said the FIR will be registered on Tuesday.

The matter came to light after officials noticed a sharp rise in medicine expenditure, which jumped from Rs 10 lakh a month to Rs 40 lakh in Feb and Rs 45 lakh in March, triggering an audit that revealed discrepancies.
Each injection costs between Rs 8,000 and Rs 10,000.

It also found cases where medicines were shown as administered without the patient being admitted. This raised suspicion of misuse of govt funds.

The inquiry flagged violations of drug management procedures. A contractual employee handled the ordering and receipt of medicines, violating the rule that assigns authorised nursing staff to perform this task.

The committee suspects that these medicines may have been diverted and is examining where the drugs were disposed of. The panel recommended criminal proceedings against the four employees.

KGMU stopped payments for medicines under scrutiny and constituted a committee on the directions of vice-chancellor Prof Soniya Nityanand.

The panel examined patient records, distribution registers and payment data. It found that medicines were shown as consumed beyond the prescribed dosage.

In several cases, an injectable drug meant to be administered once every six months was shown as administered four to five times in a month.

Related Posts

US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

Lundbeck, a biopharmaceutical company focusing exclusively on brain health, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to asedebart (Lu AG13909), Lundbeck’s novel…

Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

Fujifilm India, a leader in advanced diagnostic imaging and healthcare technology, has installed and commissioned the Fujifilm Echelon Smart MRI at Jansons Health in Erode. The installation expands access to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

Rajasthan to prepare ‘Narcotics Control Vision 2026-29’ to curb drug abuse and trafficking

Rajasthan to prepare ‘Narcotics Control Vision 2026-29’ to curb drug abuse and trafficking

Bracco Imaging expands BubbleGen cell selection with CD3+ T Cell Isolation Kit

Bracco Imaging expands BubbleGen cell selection with CD3+ T Cell Isolation Kit

5 medicine samples found substandard in Bhiwadi warehouse raid; probe launched

5 medicine samples found substandard in Bhiwadi warehouse raid; probe launched

AiMeD welcomes govt’s offer supporting development of advanced testing infrastructure

AiMeD welcomes govt’s offer supporting development of advanced testing infrastructure